WD Navarre Holdings LLC, the corporate parent of technology products distributor WYNIT Distribution LLC, filed for bankruptcy protection Friday.
NYS Entity Status
NYS Filing Date
JANUARY 21, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - MANHASSET EQUITY HOLDINGS LLC
Around the Web
- WD Navarre Holdings Files for Chapter 11 Protection
Friday Sep 8, 2017
- Angeles Equity Partners Adds Three New Team Members
By Business Wire - Tuesday Aug 15, 2017
PRESS RELEASE: Angeles Equity Partners, LLC (AEP), a private investment firm focused on value creation through operational transformation, today announced three new professionals have joined the firm. Maxwell Schechter joins the firm as Vice...
- Trump’s Tough Talk on North Korea Puts Japan’s Leader in Delicate Spot
By JONATHAN SOBLE - Friday Aug 11, 2017
North Korea’s accelerating military advances — and President Trump’s volatile response — could complicate Japan’s close alliance with the United States.
- Auction.com Parent Ten-X Gets New Ownership
Tuesday Oct 3, 2017
Private-equity firm Thomas H. Lee Partners LP has closed its purchase of a controlling stake in Ten-X LLC in a deal that values the online real estate marketplace at $1.6 billion, according to people familiar with the matter.
- Trump admin blocks Chinese buyer from taking over US tech firm
By Bob Fredericks - Wednesday Sep 13, 2017
Citing national security concerns, President Trump on Wednesday blocked a Chinese-backed investor from buying Lattice Semiconductor Corp. — only the fourth time a president has stopped a foreign takeover in 27 years. The would-be buyer, Canyon Bridge Capital Partners LLC, is a private-equity firm backed by a Chinese state-owned asset manager, Bloomberg reported. “Consistent with...
- Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
Tuesday Jun 13, 2017
Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.